Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-22

Clinical Trial Update: Buprenorphine Disposition and CYP3A [NA]

View source ↗

Summary

A completed clinical trial investigating buprenorphine disposition and CYP3A interactions; results posted but no disease focus reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Healthy | NA | Status: COMPLETED | Results posted: 2020-01-22